En vivo
MOONS'How Artemis will help the U.S. create a moon base - NBC NewsAgilentAgilent Technologies Inc (A) Shares Fall 5.0% -- What GF Score o - GuruFocusFierceBiotechDespite data concerns, Roche’s oral SERD can still be largest product in company history: execFierceBiotechRegeneron ushers in new genetic medicine era with groundbreaking gene therapy approvalThermo FisherThermo Fisher CEO says onshoring push will bring a ‘tailwind’ for the Waltham company - The Business JournalsAgilentEarnings snapshot: Agilent Technologies misses FQ1 estimates; gives FQ2 and raises FY26 outlook, above forecast - MSNThermo FisherThermo Fisher Scientific Inc. Q1 2026 Earnings Call Summary - Yahoo Finance10x Genomics BlogWhy 10x Genomics (TXG) Shares Are Trading Lower Today - TradingViewFierceBiotechKurma closes €215M Europe-focused fund to spread across 20 biotechsFierceBiotechPfizer cans work on next-gen conjugate in cancer patientsBioWorldFinancings for April 23, 2026BioWorldIn the clinic for April 23, 2026
Endpoints News 7 ene 2026

FDA in 2025 holds fewest number of adcomms since the pandemic

FDA in 2025 holds fewest number of adcomms since the pandemic

Original
Contenido no disponible. Consulta la fuente original.